About: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.53 (-8.33%)
LRMR NASDAQ Larimar Therapeutics Inc
Loading watchlist status…
Larimar Therapeutics Inc share price
LRMR price activity
Last Price
$2.530
Change (24hr)
-0.23 USD (8.33%)
Volume
431.22K
Volume (4w avg)
-
Open
$2.76
Day Range
$2.52 - $2.83
Previous Close
$2.76
Last Trade
05 Nov, 3:59 pm GMT+0
Delayed
05 Nov, 3:59 pm GMT+0
LRMR price performance
-5.24%
5D
-11.54%
1M
-33.60%
YTD
-21.43%
1Y
Delayed
05 Nov, 3:59 pm GMT+0
LRMR details
LRMR Market Signals